Literature DB >> 27812263

Clinical Significance of Rare Maternal Anti Jka Antibody.

Kshitija Mittal1, Tanvi Sood1, Naveen Bansal1, Ravneet Kaur Bedi1, Paramjit Kaur1, Gagandeep Kaur1.   

Abstract

We hereby report a rare case of HDFN because of antibody to Kidd (Jk) blood group system-anti Jka. An EDTA sample of a baby along with mother's sample was received in the Department for Direct Antiglobulin Test (DAT) alongwith blood requisition for double volume exchange transfusion. On blood grouping, baby's and mother's blood group was found to be B Rh D positive. DAT with polyspecific anti human globulin (AHG) was positive. Screening of mother's serum for irregular antibodies showed anti-Jka antibody. AHG phase titers using tube technique were 1:64. Mother was found to be Jka antigen negative; father and neonate were found to be Jka antigenpositive. Antibody was observed to be of IgG type on Dithiothreitol treatment. Baby had total serum bilirubin of 20.5 mg/dl on day 3 of life and phototherapy was started. Exchange transfusion was not required in the baby. The present case emphasises the significance of minor blood group antigens other than Rh blood group system as a cause of HDFN. Although HDFN due to Jk antibodies is rare, however, the clinician must be aware of the occurrence of these antibodies as they can lead to severe HDFN and persistent anemia in the infant.

Entities:  

Keywords:  Exchange transfusion; Hemolytic disease of fetus and newborn; Kidd antibody; Total serum bilirubin

Year:  2016        PMID: 27812263      PMCID: PMC5074971          DOI: 10.1007/s12288-016-0688-5

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN: 0971-4502            Impact factor:   0.900


  4 in total

1.  Severe hemolytic disease of the newborn caused by anti-Jka.

Authors:  G A MATSON; J SWANSON; J D TOBIN
Journal:  Vox Sang       Date:  1959-04       Impact factor: 2.144

2.  Alloimmunisation during pregnancy in Greece: need for nationwide HDFN prevention programme.

Authors:  L Foudoulaki-Paparizos; S Valsami; N Bournas; A Tsantes; P Grapsas; G Mantzios; A Travlou; M Politou
Journal:  Transfus Med       Date:  2013-07-05       Impact factor: 2.019

3.  Haemolytic disease of newborn due to anti-Jka and the duration of antibody persistence.

Authors:  Eun Jung Baek; Sung Charn Park; Young Hee Kwon; Chang-Ryul Kim
Journal:  J Paediatr Child Health       Date:  2013-01       Impact factor: 1.954

4.  Hemolytic disease of newborn due to anti-Jk b in a woman with high risk pregnancy.

Authors:  Beenu Thakral; Sheetal Malhotra; Karan Saluja; Praveen Kumar; Neelam Marwaha
Journal:  Transfus Apher Sci       Date:  2010-06-16       Impact factor: 1.764

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.